TY - JOUR AU - Hoelder, S. PY - 2012 DA - 2012// TI - Discovery of small molecule cancer drugs: Successes, challenges and opportunities JO - Mol Oncol VL - 6 UR - https://doi.org/10.1016/j.molonc.2012.02.004 DO - 10.1016/j.molonc.2012.02.004 ID - Hoelder2012 ER - TY - BOOK PY - 2017 DA - 2017// TI - British National Formulary PB - BMJ group and Pharmaceutical Press CY - London ID - ref2 ER - TY - JOUR AU - Huang, W. C. PY - 2016 DA - 2016// TI - Medication adherence to oral anticancer drugs: systematic review JO - Expert Rev Anticancer Ther VL - 16 UR - https://doi.org/10.1586/14737140.2016.1159515 DO - 10.1586/14737140.2016.1159515 ID - Huang2016 ER - TY - STD TI - Patridge A et al. Adherence to Therapy With Oral Antineoplastic Agents. Journal of the National Cancer Institute. 2002; 94(9): 652-661. Available from: https://academic.oup.com/jnci/article/94/9/652/2520164/Adherence-to-Therapy-With-Oral-Antineoplastic. Accessed 25 Nov 2017. UR - https://academic.oup.com/jnci/article/94/9/652/2520164/Adherence-to-Therapy-With-Oral-Antineoplastic ID - ref4 ER - TY - STD TI - European Organisation for Research and Treatment of Cancer. Quality of Life. Available from: http://groups.eortc.be/qol/. Accessed 25 Nov 2017. UR - http://groups.eortc.be/qol/ ID - ref5 ER - TY - STD TI - Electronic Medicines Compendium. Summary of Product Characteristics: Zelboraf 240 mg Film-coated Tablets. Available from: http://www.medicines.org.uk/emc/medicine/26056. Accessed 25 Nov 2017. UR - http://www.medicines.org.uk/emc/medicine/26056 ID - ref6 ER - TY - JOUR AU - Eisenhauer, E. A. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Kumar, S. PY - 2016 DA - 2016// TI - International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30206-6 DO - 10.1016/S1470-2045(16)30206-6 ID - Kumar2016 ER - TY - JOUR AU - Moher, D. AU - Shamseer, L. AU - Clarke, M. AU - Ghersi, D. AU - Liberati, A. AU - Petticrew, M. PY - 2015 DA - 2015// TI - Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement JO - Syst Rev VL - 4 UR - https://doi.org/10.1186/2046-4053-4-1 DO - 10.1186/2046-4053-4-1 ID - Moher2015 ER - TY - JOUR AU - Grant, M. J. AU - Booth, A. PY - 2009 DA - 2009// TI - A typology of reviews: an analysis of 14 review types and associated methodologies JO - Health Inf Libr J VL - 26 UR - https://doi.org/10.1111/j.1471-1842.2009.00848.x DO - 10.1111/j.1471-1842.2009.00848.x ID - Grant2009 ER - TY - JOUR AU - Jain, K. K. PY - 2005 DA - 2005// TI - Personalised medicine for cancer: from drug development into clinical practice JO - Expert Opin Pharmacother VL - 6 UR - https://doi.org/10.1517/14656566.6.9.1463 DO - 10.1517/14656566.6.9.1463 ID - Jain2005 ER -